AU Patent

AU2009243681B2 — Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step

Assigned to Gruenenthal GmbH · Expires 2013-12-19 · 12y expired

What this patent protects

The present invention refers to a process for preparing a powder comprising the steps of providing at least one first component being in liquid form at ambient temperature, in particular having a viscous liquid consistency, such as for example an oil; or having a waxy consistency…

USPTO Abstract

The present invention refers to a process for preparing a powder comprising the steps of providing at least one first component being in liquid form at ambient temperature, in particular having a viscous liquid consistency, such as for example an oil; or having a waxy consistency at ambient temperature, in particular a component which is a solid or semi-solid at ambient temperature and which has an onset of melting in the temperature range from 15

Drugs covered by this patent

Patent Metadata

Patent number
AU2009243681B2
Jurisdiction
AU
Classification
Expires
2013-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Gruenenthal GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.